Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or without Cirrhosis

por Berliba, Elina, Bogus, Maxim, Vanhoutte, Frédéric, Berghmans, Pieter-Jan, Good, Steven S., Moussa, Adel, Pietropaolo, Keith, Murphy, Robert L., Zhou, Xiao-Jian, Sommadossi, Jean-Pierre
Publicado 2019

Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial

por Belperio, John, Nguyen, Tuan, Lombardi, David A, Bogus, Maxim, Moskalenko, Valentyn, Singh, Dave, Haumann, Brett, Bourdet, David L, Kaufman, Elad, Pfeifer, Nathan D, Thompson, Corbin G, Woo, Jacky, Moran, Edmund J, Saggar, Rajeev
Publicado 2023

A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19

por Singh, Dave, Bogus, Maxim, Moskalenko, Valentyn, Lord, Robert, Moran, Edmund J., Crater, Glenn D., Bourdet, David L., Pfeifer, Nathan D., Woo, Jacky, Kaufman, Elad, Lombardi, David A., Weng, Emily Y., Nguyen, Tuan, Woodcock, Ashley, Haumann, Brett, Saggar, Rajeev
Publicado 2021